Ophthalmology · New York, NY
NPI
1871564963
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
115 E 61st St, Suite 1b
New York, NY, 10021
Phone (212) 355-2215
Groups this clinician bills Medicare through
Medicare paid, 2024
$560K
6,743 services
Medicare patients, 2024
1,351
Average age 77
Drug cost, 2024
$465K
3,585 prescriptions
Company payments, 2025
$9,262
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory J Pamel was code 92134 (computerized ophthalmic imaging), 2,090 times for 1,237 patients. In total Gregory J Pamel billed 6,743 services in 51 codes, and Medicare paid $560K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 2,090 | 1,237 | $32.06 | $67K |
| 92014 Ophthalmological E&M | Office | 1,444 | 1,061 | $94.54 | $137K |
| 92012 Ophthalmological E&M | Office | 716 | 394 | $74.96 | $54K |
| 92025 Test - Miscellaneous | Office | 418 | 334 | $29.30 | $12K |
| 92083 Vision, Hearing, and Speech Services | Office | 405 | 330 | $48.93 | $20K |
| 92286 Standard X-ray | Office | 333 | 296 | $27.93 | $9,300 |
| 92136 Ultrasound - Nonspecific | Office | 331 | 226 | $32.12 | $11K |
| 66984 Cataract Surgery | Facility | 247 | 156 | $460.43 | $114K |
| 92004 Ophthalmological E&M | Office | 147 | 147 | $104.59 | $15K |
| 92250 Angiography | Office | 109 | 102 | $29.42 | $3,206 |
| 99205 Office E&M - New | Office | 104 | 104 | $179.09 | $19K |
| 66821 Cataract Surgery | Office | 75 | 62 | $280.22 | $21K |
| 92020 Ophthalmological E&M | Office | 58 | 55 | $21.50 | $1,247 |
| 66982 Cataract Surgery | Facility | 52 | 34 | $587.64 | $31K |
| 76514 Ultrasound - Nonspecific | Office | 39 | 39 | $8.46 | $330 |
By year: 2022 $457K for 5,201 services; 2023 $543K for 6,200 services; 2024 $560K for 6,743 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory J Pamel prescribed most often to Medicare patients was Prednisolone Acetate, with 660 prescriptions and refills. In total Gregory J Pamel wrote 3,585 Medicare prescriptions that cost $465K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 660 | 1,116 | 397 | $42K |
| Ketorolac Tromethamine Generic | 636 | 804 | 362 | $17K |
| Ciprofloxacin Hcl Generic | 542 | 690 | 358 | $9,285 |
| Latanoprost Generic | 385 | 926 | 152 | $4,120 |
| Timolol Maleate Generic | 222 | 573 | 96 | $3,453 |
| Lumigan Bimatoprost | 216 | 523 | 83 | $134K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 109 | 205 | 43 | $1,388 |
| Dorzolamide Hcl Generic | 97 | 180 | 28 | $1,641 |
| Rhopressa Netarsudil Mesylate | 71 | 82 | 15 | $25K |
| Brimonidine Tartrate Generic | 56 | 109 | 23 | $3,873 |
| Xiidra Lifitegrast | 50 | 86 | 20 | $57K |
| Erythromycin Erythromycin Base | 50 | 52 | 22 | $892 |
| Restasis Cyclosporine | 46 | 114 | 23 | $67K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 35 | 82 | 19 | $6,221 |
| Cromolyn Sodium Generic | 35 | 39 | 17 | $336 |
Brand drugs: 1,642 claims; generic drugs: 1,943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory J Pamel $9,262 ($9,262 in general payments such as food, travel and fees) from 7 companies. The largest payer was Optos, Inc. with $8,845.
| Company | Payments | Amount |
|---|---|---|
| Optos, Inc. | 1 | $8,845 |
| Abbvie Inc. ABBV | 9 | $166 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $119 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $43.87 |
| Alcon Vision LLC ALC | 1 | $32.93 |
| RxSight Inc RXST | 1 | $32.44 |
| Dompe US, Inc. | 1 | $23.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.